蛋白/疫苗制剂

Técnicas de Secagem para Estabilização de Produtos Biofarmacêuticos

Glassy Surfactants Enable Ultra-High Concentration Biologic Therapeutics

Composition used for preparing metal oxide encapsulated drugs, comprises coated particles comprising antibody-containing core enclosed by coating layer, where antibody-containing core comprises lyophilized/spray-dried antibody, and coating layer comprises inorganic oxide e.g. aluminum oxide

Recent advances in protein precipitation-based methods for drug-target screening

Research progress on eukaryotic expression system of recombinant protein drugs

Stabilization of an Infectious Enveloped Virus by Spray-Drying and Lyophilization.

Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery.

Dry powder formulations of hyperimmune serum

Rapid Room-Temperature Aerosol Dehydration Versus Spray Drying: A Novel Paradigm in Biopharmaceutical Drying Technologies.

Effects of Formulation and Manufacturing Conditions on Protein Structure and Physical Stability

Progress in the study of autophagy-related proteins affecting resistance to chemotherapeutic drugs in leukemia

The small heat shock protein Hsp20.8 imparts tolerance to high temperatures in the leafminer fly, <i>Liriomyza trifolii</i> (Diptera: Agtomyzidae)

Innovative Technologies for Monoclonal Antibody Production and Formulation

How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part I: Contribution of processing stresses against composition.

New variable domain of camelid heavy chain-only molecule that binds receptor for advanced glycation endproducts at surface of lung cell, used to transport or deliver compound e.g. chelating agents, small drugs, amino acids, peptides, polypeptides, proteins, lipids and nucleic acids to lung

Stabilization of an Infectious Enveloped Virus by Spray-Drying and Lyophilization.

Clinical and Preclinical Methods of Heat-Stabilization of Human Vaccines

New anti-interleukin 4 receptor antibody or its antigen-binding fragment useful in pharmaceutical composition for preventing or treating inflammatory or autoimmune diseases e.g. rhinitis, conjunctivitis, periodontitis and otitis media

How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part II: Exploring each protein stabilizer effect.

Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment